Brought to you by 
ev3 completes $156.5mm IPO
16 Nov 2022
Executive Summary
Ev3 (cardiovascular devices) has netted $156.5mm with the initial public offering of 11.77mm common shares priced at $14 each. The company, which focuses on three endovascular markets--peripheral vascular, cardiovascular, and neurovascular--had hoped to bring in up to $230mm with the financing. Some ev3 shareholders also sold 36k common shares.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ev3 completes $156.5mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice